Mast Therapeutics Inc (MSTX) – Pharmaceuticals & H
Publicado el en “Mundo”, Idioma — English. 6 páginas.
Its pipeline includes development programs in the areas of adjunctive thrombolytic therapy, heart failure, resuscitation and major trauma. The company develops MST-188 utilizing its proprietary technology molecular adhesion and sealant technology (MAST). The company is headquartered in San Diego, California, the US. Más
